Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 265,771 |
|
|||||
| News | - | ||||||
| Day High | 0.019 | Low High |
|||||
| Day Low | 0.0148 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Curative Biotechnology Inc (PK) | CUBT | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.00135 | -7.42% | 0.01685 | 15:15:14 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0187 | 0.0148 | 0.019 | 0.01685 | 0.0182 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13 | 265,771 | US$ 0.015741 | US$ 4,183 | - | 0.0051 - 0.04 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 13:11:44 | 2,000 | US$ 0.01685 | USD |
Curative Biotechnology Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 10.76M | 628.92M | - | 0 | -5.69M | -0.01 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Curative Biotechnology (PK) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/06/2024 | 16:31 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CUBT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.019 | 0.0195 | 0.0148 | 0.0188603 | 81,878 | -0.00215 | -11.32% |
| 1 Month | 0.0244 | 0.025 | 0.009 | 0.0171326 | 192,658 | -0.00755 | -30.94% |
| 3 Months | 0.029 | 0.034 | 0.009 | 0.022219 | 184,451 | -0.01215 | -41.90% |
| 6 Months | 0.0124 | 0.04 | 0.009 | 0.0248533 | 246,805 | 0.00445 | 35.89% |
| 1 Year | 0.013 | 0.04 | 0.0051 | 0.0177 | 324,356 | 0.00385 | 29.62% |
| 3 Years | 0.08425 | 0.1394 | 0.0016 | 0.0468352 | 468,658 | -0.0674 | -80.00% |
| 5 Years | 0.146 | 0.19 | 0.0016 | 0.051687 | 486,341 | -0.12915 | -88.46% |
Curative Biotechnology (PK) Description
| Curative Biotechnology, Inc. (Curative Biotech) is a development stage biomedical company focused on novel therapies for rare diseases. The Company is identifying, acquiring, and developing disease modifying therapeutic drug candidates with a concentration on rare disease indications. Curative Biotech currently has ongoing programs in three (3) different therapeutic areas: degenerative eye disease, infectious disease, and neuro oncology. The Company is now concentrating its energy and resources on its degenerative eye disease platform, based on a worldwide exclusive license from the National Eye Institute (NEI) at the National Institutes of Health (NIH). The first therapeutic to be developed on this platform is a Metformin Reformulation targeting the treatment of intermediate and late-stage Age-Related Macular Degeneration (AMD) disease with the goal of being in the clinic in 2023 for a first in human trial of its metformin-based eye drop. The trial will be conducted under a Cooperative Research and Development Agreement (CRADA) with the NEI. |
